Abstract:Background Selection of patients with hepatocellular carcinoma (HCC) for orthotopic liver transplantation (OLT) remains controversial. Since there is a trend to expand the transplant criteria for HCC patients, we reviewed the data of patients with HCC who had received OLT at our institute to determine their survival and prognostic factors.Methods A total of 67 patients with HCC who had undergone OLT from April 2001 through December 2003 were reviewed retrospectively. Selection OLT candidates with HCC was dependent on the anatomical characteristics and/or the severity of underlying liver cirrhosis. The 67 patients were followed up for more than 6 months after transplantation. Their survival rate was calculated by the Kaplan-Meier method. Univariate and multivariate analyses using the Cox proportional hazards regression model were performed to reveal the factors affecting the survival rate.Results No perioperative death occurred in this series. The 1- and 2-year cumulative survival rates were 90.0% and 65.6%, and the disease-free survival (DFS) rates were 77.5% and 62.5% respectively. Univarlate analysis revealed the tumor size, portal vein tumor thrombus ( PVTT), serum alpha -fetoprotein level, bilobular distribution of tumors, pTNM stage and histological differentiation were statistically significant factors affecting the DFS (P < 0.05). Multivariate analysis showed tumor size and PVTT were independent and statistically significant factors affecting the DFS (P = 0.005 and 0.010, respectively). In this series, all but 2 received systemic chemotherapy, among them 13 had tumor recurrence within 8 months after OLT.Conclusions OLT is indicated for patients with HCC, even for some patients with end-stage liver disease who may survive longer without tumor recurrence. Adjuvant chemotherapy may decrease the recurrence of HCC after OLT.

Orthotopic liver transplantation in treatment of 77 patients with end-stage hepatic disease.

[Orthotopic Liver Transplantation for End-Stage Liver Diseases in 71 Cases].

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Clinical Orthotopic Liver Transplantation for the Treatment of End-Stage Liver Diseases

[Liver Transplantation for Treating Hepatocellular Carcinoma].

Orthotopic Liver Transplantation for Polycystic Liver Disease

Liver Transplantation for Hepatocellular Carcinoma:A Report of 60 Cases

Liver Transplantation for Patients with Hepatocellular Carcinoma at the Liver Cancer Institute of Fudan University, China.

Orthotopic Liver Transplantation in Patients over 60 Years Old

Application of Various Surgical Techniques in Orthotopic Liver Transplantation: a 10-year Experience at a Single Center

Promotion of Long-Term Survival Rate in Patients Receiving Orthotopic Liver Transplantation

The Clinical Application of Orthotopic Liver Transplantation (A Report of 9 Cases)

Perioperative Management of Orthotopic Liver Transplantation in Patients with Severe Hepatitis

Perioperative Management of Orthotopic Liver Transplantation in 48 Cases of Fulminant Hepatitis

Liver Retransplantation: Report of 80 Cases and Review of Literature.

A Retrospective Study on 22 Cases of Liver Transplantation

Treatment of Primary Liver Cancer by Orthotopic Liver Transplantation

Outcome of Orthotopic Liver Transplantation for Fulminant Hepatitis

Clinical Experience in Liver Transplantation from an Organ Transplantation Center in China.

Treatment of Fulminant Hepatic Failure and Hepatic Encephalopathy with Liver Transplantation

Therapeutic Effectiveness of Liver Transplantation: a Single Center Study of 203 Consecutive Cases